AV

Abhishek Verma

Active Director Director DIN 08996449
DIN 08996449 First appointment Dec 2020 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2020
Shareholding value •••• Premium profile

About Abhishek Verma

Data last updated:

Abhishek Verma is a Director at Pharmtox Lifesciences Private Limited (since 2020). The company operates in Chemicals. Pharmtox Lifesciences Private Limited reported revenue of ₹1.05 Cr (FY 2025).

DIN 08996449
Primary Designation Director
Industry Chemicals
First Appointment 17 Dec 2020
Oldest Company Age 5 yrs
Largest company Pharmtox Lifesciences Private Limited · ₹1.05 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director17 Dec 20202020₹1.05 Cr (FY 2025)Active

Board colleagues of Abhishek Verma

NameDINCompanyDesignation
Udit Verma08996698Pharmtox Lifesciences Private LimitedDirector

Directorship timeline

Open interactive timeline →
Pharmtox Lifesciences Private Limited
Premium access

Shareholding and investment profile for Abhishek Verma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abhishek Verma

Abhishek Verma currently holds 1 directorship: Pharmtox Lifesciences Private Limited (Director, since 17 Dec 2020, revenue ₹1.05 Cr (FY 2025)).

Abhishek Verma was first appointed on 17 Dec 2020 as Director at Pharmtox Lifesciences Private Limited.

The current boards of Abhishek Verma's companies include Udit Verma (Pharmtox Lifesciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available